CRISPR Therapeutics AG
CRSP | NASDAQ
$50.42
-$1.00 (-1.94%)
Nov 2, 2026, 11:22 AM ET · Market open
Institutional Ownership
Net InflowTotal Institutions
558
Total Ownership
80.19%
Capital Flow
+$548.77M
Shares Change
+225.39K
Ownership Distribution
Institutions (80.19%)
Others (19.81%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
81
Increased Positions
234
Reduced Positions
152
Closed Positions
52
New (81)
Increased (234)
Reduced (152)
Closed (52)
Options Sentiment & Activity
neutralPut/Call Ratio
0.944
Call Flow
1,312,000
Put Flow
1,238,100
Calls (51%)
Puts (49%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Fisher Asset Management LLC | 0.08% 0.00% | < 0.01% | 77.96K | 4.23M | |
| Tudor Investment Corp ET AL | 0.04% -2.07% | < 0.01% | 42.51K | 2.31M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Ark Investment Management LLC | 9.80% -16.78% | 3.35% -19.95% | 9.46M -16.38% | 516M -4.12% | |
| Blackrock, Inc. | 8.65% +8.19% | < 0.01% +6.01% | 8.35M +8.71% | 455.35M +24.64% | |
| Orbis Allan Gray Ltd | 5.65% -11.19% | 1.02% -16.64% | 5.45M -10.76% | 297.2M +2.32% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove CRSP